BB&T Investment Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
BB&T Investment Services's BIIB Position: Q4 2017 in Review
BB&T Investment Services increased its Biogen (BIIB) stake by 9.1% in Q4 2017, buying an estimated $22.8K and bringing the position to 849 shares worth $272K. The position accounts for 0.05% of the portfolio, ranked #259.
BB&T Investment Services first reported a position in BIIB in Q4 2016 and has held it in 5 quarters since. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.
- BB&T Investment Services held 849 shares of Biogen worth $272K as of Q4 2017.
- BB&T Investment Services bought 71 Biogen shares in Q4 2017, an estimated $22.8K.
- Biogen made up 0.05% of BB&T Investment Services's portfolio in Q4 2017, its #259 holding.
- BB&T Investment Services first reported a position in Biogen in Q4 2016 and has held it in 5 quarters since.
- 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.
Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.